Australia markets closed

DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
21.78+0.18 (+0.83%)
At close: 03:00PM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
25,336,465
24,531,390
21,248,087
16,759,335
14,582,865
Cost of revenue
16,403,413
15,724,070
13,216,858
10,365,748
8,973,435
Gross profit
8,933,052
8,807,320
8,031,229
6,393,587
5,609,430
Operating expenses
Research development
79,104
80,928
74,378
44,607
4,701
Selling general and administrative
6,205,349
5,950,976
5,468,971
4,550,213
3,677,395
Total operating expenses
7,142,487
6,892,804
6,366,341
5,198,707
4,162,620
Operating income or loss
1,790,565
1,914,516
1,664,888
1,194,880
1,446,810
Interest expense
68,216
66,219
48,235
179,759
11,497
Income before tax
1,520,425
1,627,785
1,414,895
1,043,913
1,446,410
Income tax expense
360,339
397,124
335,621
239,518
363,391
Income from continuing operations
1,160,086
1,230,661
1,079,273
804,395
1,083,019
Net income
1,068,195
1,166,498
1,035,724
791,231
1,062,181
Net income available to common shareholders
1,068,195
1,166,498
1,035,724
791,231
1,062,181
Basic EPS
1.13
1.03
0.91
0.70
0.94
Diluted EPS
1.13
1.03
0.91
0.70
0.94
Basic average shares
1,140,513
1,132,523
1,138,158
1,130,330
1,132,993
Diluted average shares
1,140,513
1,132,523
1,138,158
1,130,330
1,132,993